PenderFund Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

PenderFund Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,450	Closed	-$785K	–	171
2022 Q4	$785K	Buy	17,450 +4,900	+39%	+$158K	0.23%	60
2022 Q3	$547K	Buy	+12,550	New	+$406K	0.17%	72

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PenderFund Capital Management's VIVO Position: Q1 2023 in Review

PenderFund Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 17,450 shares — an estimated $785K sold.

PenderFund Capital Management first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $785K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

PenderFund Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
PenderFund Capital Management sold 17,450 Meridian Bioscience Inc shares in Q1 2023, an estimated $785K.
PenderFund Capital Management first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
PenderFund Capital Management's Meridian Bioscience Inc position peaked at $785K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on PenderFund Capital Management's 13F filing for Q1 2023, filed 15 May 2023.